Literature DB >> 2008

Responses to drug therapy in ulcerative colitis. Evaluation by rectal biopsy and histopathological changes.

B I Korelitz, S C Sommers.   

Abstract

To evaluate responses to medical therapy in ulcerative colitis, rectal biopsies of patients with active untreated disease, individuals with positive and negative sigmoidoscopic findings treated with salicylazosulfapyridine, prednisone and 6-mercaptopurine, alone and in combinations and noncolitis controls were compared histologically. Predominant histological observations were analyzed statistically. There were fewer crypt abscesses but more mucosal edema after all forms of therapy. Quantitative histopathological analysis failed to demonstrate that the response to one drug was significantly different from another.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 2008

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

1.  Responses to drug therapy in ulcerative colitis. Evaluation by rectal biopsy and mucosal cell counts.

Authors:  B I Korelitz; S C Sommers
Journal:  Am J Dig Dis       Date:  1976-06

2.  Incidence and risk factors for lymphoma in a single-center inflammatory bowel disease population.

Authors:  Michael V Chiorean; Bhupesh Pokhrel; Jaya Adabala; Debra J Helper; Cynthia S Johnson; Beth Juliar
Journal:  Dig Dis Sci       Date:  2010-10-15       Impact factor: 3.199

3.  Autofluorescence imaging endoscopy for identification and assessment of inflammatory ulcerative colitis.

Authors:  Taro Osada; Atsushi Arakawa; Naoto Sakamoto; Hiroya Ueyama; Tomoyoshi Shibuya; Tatsuo Ogihara; Takashi Yao; Sumio Watanabe
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

4.  Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.

Authors:  Burton I Korelitz; Keith Sultan; Megha Kothari; Leo Arapos; Judy Schneider; Georgia Panagopoulos
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

5.  DNA flow cytometric evaluation of cell cycle distribution in ulcerative colitis: a proposed method for assessing severity of disease.

Authors:  F Bortoluzzi; M Valentini; C Cernigoi; G Toffoli; M Boiocchi; M Poletti; M Sozzi; M Fornasarig; R Cannizzaro; E Bertolissi
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

Review 6.  Value of colonoscopy for prediction of prognosis in patients with ulcerative colitis.

Authors:  Takafumi Ando; Yuji Nishio; Osamu Watanabe; Hironao Takahashi; Osamu Maeda; Kazuhiro Ishiguro; Daisuke Ishikawa; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

7.  Microscopic activity in ulcerative colitis: what does it mean?

Authors:  S A Riley; V Mani; M J Goodman; S Dutt; M E Herd
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

8.  Magnifying chromoscopy, a novel and useful technique for colonoscopy in ulcerative colitis.

Authors:  Takafumi Ando; Hironao Takahashi; Osamu Watanabe; Osamu Maeda; Kazuhiro Ishiguro; Daisuke Ishikawa; Motofusa Hasegawa; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

9.  Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.

Authors:  Ariane Desselle; Tanguy Chaumette; Marie-Hélène Gaugler; Denis Cochonneau; Julien Fleurence; Nolwenn Dubois; Philippe Hulin; Jacques Aubry; Stéphane Birklé; François Paris
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

10.  Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats.

Authors:  Toru Miyoshi; Kazufumi Nakamura; Masashi Yoshida; Daiji Miura; Hiroki Oe; Satoshi Akagi; Hiroki Sugiyama; Kaoru Akazawa; Tomoko Yonezawa; Jun Wada; Hiroshi Ito
Journal:  Cardiovasc Diabetol       Date:  2014-02-13       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.